Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Joan T. Merrill's publication output changed over time?
ScholarIQpublication output · 2005–2016
Output declined67% over the shown period — from 3 works in 2005 to 1 in 2016.
3
2
1
2
1
2
1
2005200920112012201420152016
What are the most-cited papers on Joan T. Merrill?
ScholarIQmost cited works
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Michelle Petri, Ana‐Maria Orbai, Graciela S. Alarcón, Caroline Gordon, Joan T. Merrill, Paul R. Fortin, Ian N Bruce, David Isenberg, Daniel J. Wallace, Ola Nived, Gunnar Sturfelt, Rosalind Ramsey‐Goldman, Sang‐Cheol Bae, John G. Hanly, Jorge Sánchez‐Guerrero, Ann E. Clarke, Cynthia Aranow, Susan Manzi, Murray Urowitz, Dafna D. Gladman, Kenneth Kalunian, Melissa Costner, Victoria P. Werth, Asad Zoma, Sasha Bernatsky, Guillermo Ruiz‐Irastorza, Munther A. Khamashta, Søren Jacobsen, Jill P. Buyon, Peter J. Maddison, Mary Anne Dooley, Ronald van Vollenhoven, Ellen M. Ginzler, Thomas Stoll, Christine Peschken, Joseph L. Jorizzo, Jeffrey P. Callen, S. Sam Lim, Barri J. Fessler, Murat İnanç, Diane L. Kamen, Anisur Rahman, Kristján Steinsson, Andrew G. Franks, Lisa Sigler, Suhail Hameed, Hong Fang, Ngoc Minh Pham, Robin L. Brey, Michael H. Weisman, Gerald McGwin, Laurence S. Magder
S132787887. 20125,341 CitationsOPEN ACCESS
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J. Wallace, Dana Tegzová, Jorge Sánchez‐Guerrero, Andreas Schwarting, Joan T. Merrill, Winn Chatham, William Stohl, Ellen M. Ginzler, Douglas R. Hough, Z. John Zhong, William W. Freimuth, Ronald van Vollenhoven, BLISS-76 Study Group
S132787887. 20111,675 CitationsOPEN ACCESS
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
Bevra H. Hahn, Maureen McMahon, Alan Wilkinson, William D. Wallace, David Daikh, John FitzGerald, George Karpouzas, Joan T. Merrill, Daniel J. Wallace, Jinoos Yazdany, Rosalind Ramsey‐Goldman, Karandeep Singh, Mazdak A. Khalighi, Soo‐In Choi, Maneesh Gogia, Suzanne Kafaja, Mohammad Kamgar, Christine Lau, W. J. Martin, Sefali Parikh, Justin Peng, Anjay Rastogi, Weiling Chen, Jennifer M. Grossman
Arthritis Care & Research. 20121,487 Citations
Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
Joan T. Merrill, C. Michael Neuwelt, Daniel J. Wallace, Joseph C. Shanahan, Kevin Latinis, Jim C. Oates, Tammy O. Utset, Caroline Gordon, David Isenberg, Hsin‐Ju Hsieh, David Zhang, Paul Brunetta
S132787887. 20091,405 CitationsOPEN ACCESS
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus
Michelle Petri, Mimi Kim, Kenneth Kalunian, Jennifer Grossman, Bevra H. Hahn, Lisa R. Sammaritano, Michael D. Lockshin, Joan T. Merrill, H. Michael Belmont, Anca Askanase, W. Joseph McCune, Michelene Hearth-Holmes, Mary Anne Dooley, Joan Von Feldt, Alan Friedman, M Tan, John C. Davis, Mary E. Cronin, Betty Diamond, Meggan Mackay, Lisa Sigler, Michael Fillius, Ann Rupel, Frederick Licciardi, Jill P. Buyon
New England Journal of Medicine. 20051,169 CitationsOPEN ACCESS
Related on ScholarIQ
Oklahoma Medical Research Foundation
Institution
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Paper
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Paper
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
Paper
Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
Paper
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus
Paper